Pharmacokinetic studies of ginsenosides Rk1 and Rg5 in rats by UFLC–MS/MS. (10th March 2021)

• Record Type: Journal Article
• Authors: Ma, Chao; Lin, Qiyan; Xue, Yafu; Ju, Zhengcai; Deng, Gang; Liu, Wei; Sun, Yuting; Guan, Huida; Cheng, Xuemei; Wang, Changhong
• Is Part Of: Biomedical chromatography. Volume 35:Number 8(2021)
• Page Start: n/a
• Page End: n/a
• Publication Date: 2021-03-10
• Subjects: ginsenoside Rg5 -- ginsenoside Rk1 -- pharmacokinetics; Chromatographic analysis -- Periodicals; Biology -- Periodicals; Medicine -- Periodicals; Biology -- Periodicals; Chromatography -- methods -- Periodicals; Medicine -- Periodicals; 543.089
• DOI: 10.1002/bmc.5108
• Languages: English
• ISSNs: 0269-3879

Abstract

Abstract: A rapid ultra‐fast liquid chromatography tandem mass spectrometry method was developed and validated to determine ginsenosides Rk1 and Rg5, a pair of isomers, in rat plasma, which was successfully applied to their pharmacokinetic studies. Two ginsenosides were given to male Sprague–Dawley rats via intragastrical and intravenous routes, respectively, and the impact of double bond position on the pharmacokinetic features of the two ginsenosides was elucidated in rats. Ginsenoside Rg3 was used as internal standard and ethyl acetate was applied to extract analytes and internal standard. Chromatographic separation was carried out on a reverse‐phase UPLC HSS T3 column (100 × 2.1 mm, 1.8 μm). The flow rate was set to 0.4 ml/min. The fragmentation transition was m/z 765.4 → m/z 101.1 for two ginsenosides. The mobile phases were composed of 0.1% formic acid aqueous solution and acetonitrile. The linear range was 2–1, 000 ng/ml for the two ginsenosides. Intra‐ and inter‐day precisions were <11.67%, and accuracy fluctuated from −7.44 to 6.78%. The extraction recovery, matrix effect and stability were within acceptable levels. After treatment with ginsenosides Rk1 and Rg5, some differences were found in their pharmacokinetic profiles in rats. The maximum plasma drug concentration and the area under the plasma drug concentration–time curve of ginsenoside Rg5 were about 5 times bigger than those of ginsenoside Rk1 after oral administration, and 3 times higher after intravenous administration. The oral bioavailabilities of ginsenosides Rk1 and Rg5 were 0.67 and 0.97%, respectively. The results indicated that ∆ 20(22) ‐ginsenosides showed better pharmacokinetic features than ∆ 20(21) ‐ginsenosides with the same glycosylation.